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Introduction
Since antiquity, Coptidis Rhizoma (Coptis) has been administered 
as an ancient remedy. In Traditional Chinese Medicine (TCM), coptis 
is used to treat conditions associated with Qingre Zaoshi (clearing heat 
and removing dampness), Xiehuo Jiedu (purging fire to eliminate toxin) 
such as diarrhea, eye inflammation and women’s abdomen ailments 
[1,2]. Recent studies have disclosed its potential to combat cancer, 
inflammation, fibrosis, viral and bacterial infections, and oxidation [3-
10]. Coptis and its main ingredient, berberine, show significant effects 
on cancer with a multiple targets including mitochondrial [11], NAG-1 
[12,13], topoisomerases [14], estrogen receptors [15], p53 [16,17], NF-
κB [18,19] and ROS [20]. Our previous studies indicated that Coptis 
extracts activated miR-21 and miR-23a in human liver cancer [21], 
we also found that Coptis and berberine initiated autophagy in liver 
cancer by activating Beclin-1 and blocking mTOR-signaling way by 
suppressing the activity of Akt and inducing p38 MAPK activation 
[22]. 
According to China Pharmacopoeia (2010), three species could 
be the resources of Coptis, including Coptis chinensis Franch, Coptis 
deltoidea C.Y. Cheng et Hsiao and Coptis teeta Wall [23], among 
which Coptis chinensis Franch (Huanglian in Chinese, HL) and 
Coptis teeta Wall (Yun Huanglian or Yunlian, YHL) are two main 
medical products from Sichuan Province and Yunnan Province, 
respectively. Chemical analysis have determine Berberine to be 
Huanglian’s active components, and other trace alkaloids include 
palmatine, columbamine, jatrorhizine, epiberberine, copsitine, and an 
aporphinoid alkaloid-magnoflorine [24]. However, it shall be necessary 
to provide scientific evidence to show the bioequivalence of HL and 
YHL in certain pharmacoligcal aspects.
In this study, we compared the chemical compositions and tumor 
suppressive effects in vitro between Huanglian and Yunlian. High 
performance liquid chromatography (HPLC) and HPLC combined 
with mass spectrometry (LC-MS) were facilitated to determine 
berberine and other alkaloids and their ratio. As we previously found 
that berberine effectively inhibited cell migration and invasion at low 
doses by induction of Rho GTPases including RhoA, Cdc42 and Rac1 
[25]. Inhibition of huanglian and yunlian on migration and invasion in 
human hepatocellular carcinoma cell line MHCC97L was investigated 
in this study as well.
Materials and Methods
Preparation of HL and YHL Aqueous Extracts
Dried HL and YHL herbs were collected from Sichuan and Yunnan 
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Abstract
Objective: Coptidis Rhizoma is a famous Chinese medicinal herb for its potential to combat cancer, inflammation, 
fibrosis, viral and bacterial infections, and oxidation. Coptis chinensis Franch (Huanglian in Chinese HL) and Coptis 
teeta Wall (Yun Huanglian or Yunlian YHL) are two species of Coptidis Rhizoma commonly used in Traditional 
Chinese Medicine. Huanglian is produced from Sichuan Province, while Yunlian comes from the Yunnan Province. 
Both provinces are located in China. There are indications that both herbs possess similar characteristics and 
functions in clinical use. However, there are no signs of prior research to compare the effects of HL and YHL on 
hepatocellular carcinoma. In this study, we compared the components and anti-liver cancer effects in vitro between 
Huanglian and Yunlian.
Methods: HPLC was introduced to analyze the active components in Huanglian and Yunlian aqueous extracts. 
Liquid chromatography with mass spectrometry and High performance liquid chromatography with UV detector were 
used to identify and compare the main ingredients ratio between Huanglian and Yunlian extracts. Cytotoxicity and 
apoptosis affected by the two extracts on MHCC97L cell line was observed by using MTT assay and flow cytometry, 
respectively. The inhibition of metastasis and invasion in hepatocellular carcinoma cell line MHCC97L by Huanglian 
and Yunlian were compared as well. 
Results: Results of phytochemical analysis showed there were no significant differences between the two herbs’ 
ingredients and ratios. Also, there were no significant differences between Huanglian and Yunlian on cytotoxicity, 
apoptosis and metastasis in MHCC97L.
Conclusion: Yunlian and Huanglian share great similarities in both chemical compostion and bioactivity in vitro. 
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Province of China respectively and authenticated under the guidance 
of Chinese Pharmacopoeia (2010). They were identified by School of 
Chinese medicine, the University of Hong Kong. 500 g of each was 
boiled in 10 times of distilled water (w/v) at 100°C for 1 hour and 
percolated through filter paper (Whatman, pleated filter grade 597 1/2, 
4–7 μm) and then sterilized by filtration through a 0.2 μm pore filter 
(Minisart®-plus, Sartorius). The filtrate was further concentrated and 
the dry extract powder was collected and stored at -20°C until used.
Cell line 
Human hepatocellular carcinoma cell line MHCC97L was kindly 
gifted by Dr. Man Kwan, Department of Surgery, and The University of 
Hong Kong. Cells were cultured in DMEM medium (Invitrogen, USA), 
and incubated in a humidified atmosphere containing 5% CO2 at 37°C.
Identification of chemical composition of HL and YHL 
extracts by LC-MS 
LC-MS (Thermo Finnigan, USA) was used to identify the chemical 
composition of HL and YHL extracts. Both HL and YHL extract powders 
were dissolved in methanol and diluted to proper concentration. 10 μl 
of sample solution was injected to the LC-MS [26-28].
Quantification of active components of HL and YHL extracts 
by HPLC 
HPLC (Water 996 Photodiode Array Detector, Waters 717plus 
Autosampler, Water 600S Controller, Empower Pro Analysis system, 
USA) was introduced to analyze the active components in herb extracts 
as described previously [29-31].
Cell viability assay
In vitro cytotoxicity of HL and YHL extracts on MHCC97L cells 
was observed using MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide) assay system. 1×104 cells with 100 μl of medium 
per well were seeded in 96-well plates, incubated, and treated with 
different concentrations of HL and YHL for 24, 48, and 72 hrs, 
respectively. At the end of each treatment, 10 μl of MTT (5 mg/mL) 
was added to the well and incubated for 4 hrs. The absorbance was read 
at 575 nm with Multiskan MS microplate reader (Labsystems, Finland).
Annexin v/PI staining
Cells were seeded in 35-mm petri-dish with 80% confluence and 
treated with different concentrations of HL and YHL for 24 hrs. After 
treatment, cells were collected using micro-scraper (Corning, USA) 
and then centrifuged. To detect apoptosis in MHCC97L cells, Annexin 
V/PI double staining kit (Sigma-aldrich, USA) was introduced to 
quantify cell amount in different stages of cell death. Briefly, cells were 
resuspended in 1 mL of binding buffer containing 100 mM HEPES/
NaOH, 1.4 M NaCl, 25 mM CaCl2, pH 7.5. Then 5 μl of FITC-conjugated 
Annexin V (50 μg/mL) and 10 μl of propidium iodide (100 μg/mL) 
were added to the cell suspension. Incubation of cells was performed in 
dark for exactly 10 minutes at room temperature and detected by flow 
cytometer (Epics XL, Beckman Coulter, USA).
Wound healing assay 
MHCC97L cells were seeded in 6-well plates and waited for full 
confluence attained. To introduce uniform wound on the confluent 
monolayer cells, a gap was scraped by using a micro-pipette tip on each 
well. After wound introduction, culture medium was replaced with 
fresh medium containing different concentrations of HL and YH. To 
compare the speed of wound closure between berberine treated and 
untreated cells, photographs were taken under 100x magnifications 
using phase-contrast microscopy immediately after wound incision (0 
h) and after 24 hrs.
Invasion chamber assay
The experiment was conducted under the manufacturer’s 
instruction (QCMT 96-well cell invasion assay kit, Millipore, USA). 
Briefly, 100 μl of pre-warmed serum free media was placed into the 
invasion chamber and the plate was incubated for 1 hour at room 
temperature. After rehydration of chamber, media were removed and 
150 μl serum free media in the presence of 10% fetal bovine serum 
were added to the feeder tray. 100 μl serum free media with 1×104 
MHCC97L cells were then placed into invasion chamber. A series of 
concentrations of agents were added to cell suspension and incubated 
for 24 hours at 37°C, 5% CO2. Then media with cell suspension in each 
chamber were discarded and the chamber plate was plated onto a new 
feeder tray containing 150 μl PBS in each well and incubated for 1 
minute at room temperature. After rinsing with PBS as described, PBS 
was removed and 150 μl of pre-warmed cell detachment solution were 
added to the feeder tray and the chamber plate was incubated for 30 
minutes at 37°C. This step was followed by addition of 50 μl of lysis 
buffer/dye and 15 minutes incubation at room temperature. 150 μl of 
the mixture was transferred to a new 96-well black plate and read it 
using 480/520 nm filters set using a fluorescence plate reader.
Statistical analysis
Data was computed using student T-test and expressed as mean 
± SD. Experiments were repeated three times. P<0.05 was considered 
significantly difference.
Results
Identification of chemical composition in HL and YHL 
extracts by LC-MS 
7 peaks, magnoflorine, columbamine, jatrorhizine, epiberberine, 
copsitine, palmatine, and berberine were identified as major alkaloids 
in both HL and YHL extracts as reported previously [26,27]. No 
significant difference of chemical composition between HL and YHL 
extracts was observed (Table 1).
Quantification of active components in HL and YHL extracts 
by HPLC 
Area of 5 main peaks were determined and calculated as a percentage 
of total area. Data indicated there was no difference between the two 
herbal extracts (Figure 1 and Table 1). It was shown that berberine is the 
major active compound in both HL and YHL. The yields of berberine 
in HL and YHL were 32.14% and 30.96% respectively.
Magnoflorine Jatrorhizine Coptisine Palmatine Berberine
% in HL 4.49 7.84 10.22 12.89 32.14 
% in YHL 2.33 4.81 8.21 9.76 30.96 
Table 1: Summary of active components in HL and YHL. The phytochemical 
analysis was performed under the following condition: Reserve C18 column 
(Symmetry®, 250 mm x 4.0 mm, 5 µm) was used as solid phase; elution was 
performed using acetonitrile-25 mM potassium dihydrogen phosphate (23:77) 
as mobile phase. Detecting wavelength and flow rate was 254 nm and 1.0 ml/
min respectively. The analysis was performed under room temperature. Area of 5 
main peaks were calculated as a percentage of total area. There is no significant 
difference between two herbs.
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Cytotoxicity effects of HL and YHL extracts on MHCC97L 
cells
MHCC97L cells treated with HL and YHL extracts for 24, 48 
and 72 hrs were conducted and calculated. To better examine the 
bioequivalence between HL and YHL, the IC50 value of HL and YHL 
was determined and the data was presented by showing the yield of 
berberine contained by the extracts. IC50 value for HL was 340, 170 
and 170 μM for 24, 48 and 72 hours, respectively, while for YHL was 
380, 150 and 180 μM. Both of HL and YHL extracts exhibited potent 
cytotoxicity on MHCC97L with a dose-dependent manner in 48 hours 
(Figure 2). 
HL- and YHL- induced apoptosis in MHCC97L Cells
The results showed that HL and YHL significantly induced early 
and median apoptosis in MHCC97L cells after 24 hours treatment. The 
induction of apoptosis by HL and YHL was slightly enhanced in line 
with increased doses. There was no large difference in potency between 
HL and YHL for inducing apoptosis in the MHCC97L cell line (Figure 
3).
HL and YHL inhibit metastasis of MHCC97L cells by wound 
healing assay
It was observed that MHCC97L cells at the opposite edges of the 
wounds rapidly migrated toward each other after 24 hrs of incubation. 
With increasing doses, the speed of wound healing slowed down, the 
gap remained open, and only minimal cell proliferation on the 2 edges 
of the wound was observed when cells were incubated with 200 μM of 
HL and YHL. Cell motility was remarkably inhibited with HL and YHL 
exposure. Photographs of cells with different treatment were taken and 
displayed in Figure 4.
HL and YHL inhibit invasion of MHCC97L cells
The results of chamber assay combined with MTT assay showed 
promising inhibitory effects of HL and YHL on the invasion of 
MHCC97L cell line. The results also showed that HL and YHL 
suppressed the metastasis of MHCC97L at the doses far lower than 
their IC50 values. HL and YHL showed no difference in their capability 
to suppress cell invasion (Figure 5).
Discussion
In Chinese Pharmacopoeia, HL and YHL belong to the same genus, 
Coptis, and both herbs could be administered in Traditional Chinese 
Medicine clinics, and are important components in Chinese medicine 
herbal formulae. There are indications that both herbs possess similar 
characteristics and functions in clinical use. However, there are no 
signs of prior research to provide any scientific observation on the 
pharmacological similarities of HL and YHL. In this study, we have 
been able to identify the active ingredients in HL and YHL by LC-
MS. The HPLC-UV chromatograms of HL and YHL extracts showed 
that there was no significant difference in the chemical composition 
between the two extracts. The quantification of active components in 
HL and YHL was obtained by HPLC where there were no remarkable 
variation of the yields of major active alkaloids observed between 
HL and YHL, indicating that HL and YHL share great similarities in 
chemical composition.
To compare the bioactivity of HL and YHL, MTT Assay and 
flow cytometry were employed. As we previously found that coptis 
and berberine effectively inhibit cell metastasis and invasion at low 
doses by induction of Rho GTPases including RhoA, Cdc42 and Rac1 
[25]. Wound healing and invasion chamber assay were conducted 
to compare the inhibition of metastasis and invasion between HL 
and YHL. Both of HL and YHL showed similar cytotoxicity in serial 
concentrations. We used Annexin V/PI double-staining to monitor 
apoptosis induced by HL and YHL. Both HL and YHL can significantly 
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Figure 1: HPLC Chromatograms of HL extract and YHL extracts. A. HL ex-
tracts; B. YHL extracts. 
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Figure 2: Viability of MHCC97L after treatments with HL and YHL for 
24,48,72 hrs (Mean±SD). MHCC97L cells were treated with HL and YHL ex-
tracts for 24h (A), 48h (B), and 72h (C). Each concentration was tested in tripli-
cate wells. Each experiment was repeated three times while standard deviation 
served as the error bars. The results showed no significant difference of effects 
between HL and YHL extracts (P<0.05).
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Figure 3: HL- and YHL- induce apoptosis in MHCC97L cells. MHCC97L cells 
were treated with HL and YHL for 24hrs. Annexin V/PI double-staining was used 
for flow cytometry (FCM). A. control; B. HL extracts 150μM; C. YHL extracts 
150μM; D. HL extracts 300μM; E. YHL extracts 300μM.
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Figure 4: Anti-metastasis of agents in different time points. MHCC97L cells 
were treated with HL and YHL at different concentrations for 0 and 24 hrs. Dis-
tance between the two opposite edges wound was captured and recorded at 
the relative time points. There is no significant difference between two herbal 
extracts.
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Figure 5: Comparison of invasion inhibitory between HL and YHL in 24hrs. 
HL and YHL extracts at the concentration of 12.5, 25, 50, 100, 200, and 400μM 
were added to cell suspension and incubated for 24 hours at 37, 5% CO2. Data 
indicated there is no difference between HL and YHL extracts on invasion of 
MHCC97L cells.
induce apoptosis in MHCC97L cells after 24 hours treatment. There 
was no large difference in potency between HL and YHL for inducing 
apoptosis in the MHCC97L cell line. Wound-healing assay was 
introduced to qualitatively determine the migration of MHCC97L cells 
with exposure to HL and YHL. Cell motility was remarkably inhibited 
under exposure with either HL or YHL. Moreover, the results of 
invasion chamber assay indicated HL and YHL showed no difference 
in their capability to suppress cell invasion.
In conclusion, HL and YHL share great similarities in both chemical 
composition and inhibitory effect on HCC growth and metastasis. In 
addition, we also found that other ingredients in HL and YHL presented 
a synergetic interaction with berberine which increased the late effects 
on cancer (data not shown). This sheds light on the application of HL 
and YHL as HCC therapeutic agents and deserves further studies. 
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